# A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis

> **NCT05316311** · NA · COMPLETED · sponsor: **Medos International SARL** · enrollment: 194 (actual)

## Conditions studied

- Intracranial Atherosclerosis

## Interventions

- **DEVICE:** CERENOVUS ENTERPRISE 2 Intracranial Stent

## Key facts

- **NCT ID:** NCT05316311
- **Lead sponsor:** Medos International SARL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-24
- **Primary completion:** 2025-12-24
- **Final completion:** 2026-02-06
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316311, "A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05316311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*